Advertisement
  • Facts and Stats

    A Quarter Century of Progress Against Lung Cancer

    While advances have been made in treating lung cancer and risk reduction, there is still plenty of work to be done.

    by Bradley Jones

  • Survivor Profile

    Sharing Her Strength

    Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

    by Lindsey Konkel

  • Robotic Surgery and Cancer

    Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

    by Sue Rochman

  • A Modern Family

    My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.

    by Allison Rosen

  • Why Are Early-Onset Cancers Rising?

    Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.

    by Kate Yandell

  • Pediatric Oncologists Underestimate Needs of Minority Parents

    Research describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups.

    by Marci A. Landsmann

  • Why Skip a Dose?

    A survey of over 1,000 breast cancer patients prescribed endocrine therapy sheds light on low adherence.

    by Emma Yasinski

  • When COVID-19 Comes Home

    I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.

    by Adam Hayden

  • What It’s Like to Get a “C” in Graduate School

    I was afraid that my thyroid cancer diagnosis would derail my graduate school plans. Instead, it helped shape my career path.

    by Carly Flumer

  • Tumor Testing May Help Guide Pancreatic Cancer Treatment

    For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.

    by Cheryl Platzman Weinstock